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Paravalvular leaks (PVL) after valve replacement surgeries are not uncommon. A significant
number of these patients need some form of intervention as they commonly present with
heart failure or severe hemolysis. Surgical correction is associated with high mortality and
morbidity. Device closure of PVLs has been found to have good results. Since there are no
devices designed specifically for PVL closure, large PVL closure is difficult. Occasional larger
PVLs have been closed with a combination of a device and smaller coils. We present here a
case of very large sized mitral PVL, in a patient with high risk for surgery, which was closed
with two large size devices.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Mitral paravalvular leak (PVL) subsequent to valve replace-
ment surgery is not an uncommon occurrence having been
reported in upto 4.5% of cases.1,2 Most of these cases are
asymptomatic but a significant number need some form of
intervention. Surgery is the standard treatment for such cases
but is associated with high morbidity and mortality. Mortality
rates are as high as 13, 15, and 37% after the first, second, and
third procedures, respectively.3 Percutaneous device closure
of PVLs is an acceptable mode of intervention for such pa-
tients and has shown good survival benefit.4 The long-term
result correlates with the degree of residual mitral regurgita-
tion (MR). We report a case which presented with severe MR,.
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2014, Cardiological Societcausing symptoms of heart failure, due to a large mitral valve
PVL and needed two large devices for percutaneous device
closure of the PVL.2. Case history
A 25-year-oldmale patient presented to us with NYHA class III
dyspnea with history of having needed 2e3 hospital admis-
sions for acute pulmonary edema in the last 6 months. He has
had mitral valve replacement done 8 years back with a Starr
Edward valve and had chronic persistent atrial fibrillation.
Echocardiography done showed a very large PVL at the 9
O’clock position in the parasternal short axis view measuringy of India. All rights reserved.
Fig. 1 e a e Shows preprocedure severe mitral regurgitation through a large PVL, b e Shows post procedure mild residual
mitral regurgitation.
Fig. 2 e Two 032 wires have been taken through the PVL
and then across the aortic valve and parked in the
subclavian artery (not seen in figure). The sheath can be
seen having been tracked over the wires through the PVL
into the LV.
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(Fig. 1a) with dilated left atria (measuring 68 mm in para-
sternal long axis view) and left ventricle with mild left ven-
tricular (LV) systolic dysfunction (LV ejection fraction of 45%).
The patient, after being explained different management op-
tions, refused surgery and was hence taken up for a device
closure after obtaining an informed written consent.
The procedure was carried out under local anesthesia with
transthoracic echocardiography guidance. While a trans-
esophageal approach may give better guidance and visibility,
we opted for transthoracic guidance to avoid a prolonged
general anesthesia and also for the fact that the patient had a
Starr Edward valve which has a good profile under fluoros-
copy. An antegrade approach for device closure was planned.
A routine transseptal puncture was done and a 14F Mullins
sheath (Cook Inc, Bloomington, IN) was lodged in the left
atrium (LA). Since the left atriumwas significantly dilated and
the PVL was located relatively medially, we made a conscious
decision not to make a high septal puncture which is advis-
able for laterally located PVLs. The PVL was crossed with a
180 cm, 0.035 inch, curve tipped Glide wire (Terumo Medical
Corp., Somerset, New Jersey) taken with a 5F Judkins Right (JR)
catheter through this sheath. The JR catheter was taken across
the PVL after confirming that thewirewas not across the valve
in orthogonal fluoroscopic views. Once inside the LV, the wire
was exchanged for a 300 cm, 0.032 inch Amplatz ExtraStiff
wire (Cook Medical, Bloomington, Indiana). This wire was
taken across the aortic valve and positioned in the right sub-
clavian artery. Another 0.032 Amplatz ExtraStiff wire was
similarly taken across the PVL and positioned alongside the
first wire. The 14F sheath could now be taken across the PVL,
over these two wires, without any resistance (Fig. 2). Once in
the LV, one of the wires was removed and a 16/18 mm
Amplatzer duct occluder like device (Cardio-O-Fix PDA
occluder, Starway Medical Technology Inc., Beijing, China)
was deployed across the PVL. Echocardiography done showed
a significant persistent regurgitation. It was hence decided to
deploy another device across the PVL. To ensure more sta-
bility, an Amplatzer muscular VSD closure device (AGA Med-
ical Corp., Plymouth, Minnesota) was selected as the seconddevice. A 12 mm device easily fell across the PVL with the first
device in place. It was hence decided to use an 18 mm device.
The first device was resheathed and the 14F sheath was
lodged across the PVL in the LV with both the devices (Fig. 3).
The distal one third of both the devices were exteriorized out
of the sheath on the LV side and the whole assembly was
pulled back to the level of the valve ensuring that the two
distal rims were aligned side by side and not affecting the
movement of the ball within the valve. The sheath was now
gradually pulled back exteriorizing the proximal ends of the
two devices. Echocardiogram showed minimal residual MR.
Both the devices were released. A stable position was
confirmed by both echocardiogram and fluoroscopy.
Fig. 3 e Distal rims of both devices have been opened in the
LV simultaneously to prevent the devices from slipping
back into the LA.
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aspirin alongwith other heart failure drugs since then. Hewas
fine at 1-year follow up with significant improvement in his
symptoms to NYHA functional class II and minimal residual
MR (Fig. 1b).3. Discussion
Most PVLs are asymptomatic and need no intervention.
However, a small minority of cases become symptomatic and
need some form of intervention. The most common reasons
for presentation in patients with PVL include congestive heart
failure (CHF) and hemolytic anemia with a significant number
of patients having both.4,5 Surgical repair is probably the gold
standard for treatment of a PVL. However, the morbidity and
mortality with a repeat procedure is significantly high and
many of the patients are hesitant to undergo another surgery
with a higher risk. This has evinced a keen interest in finding
alternative minimally invasive methods for their manage-
ment. Device closure of PVLs has been reported in a large
number of patients and has shown increasingly good results,
especially after the improvement in the available hardware
for intervention. Short-term follow up results have been very
good with 3-year survival rates of almost 70%.4 Considering
that most such closures are done in patients with high sur-
gical risk, it is now an acceptable mode of treatment for PVLs.
Our patient with severe MR, associated early LV dysfunc-
tion and NYHA class III symptoms was a high-risk surgical
candidate and the patient opted for a device closure. Echo-
cardiography done showed that the PVL was at 9 O’clock po-
sition and measured 15e17 mm by echo. While there have
been earlier case reports of PVLs needing more than one de-
vices, none has been reported to have needed two such largedevices. The resulting MR almost filled the whole LA. The long
term results of PVL closure depends on the residual MR and
since this patient had presented with heart failure symptoms,
it was important to ensure minimal residual MR post proce-
dure. For mitral PVLs, the antegrade approach is the preferred
route for device closure.6,7 It is important to cross the PVL
carefully without affecting the valve function. We confirmed
the wire route by multiple orthogonal fluoroscopic and echo-
cardiographic views before taking the catheter across.
Amplatzer duct occluder is the most common device used
to close the PVLs.5 We too used an Amplatzer duct occluder
like device based on the echocardiographic estimation of the
size. However, we had thought that this alone may not be
sufficient to close the PVL. This is because of the fact that the
PVLs are semilunar shaped defects and none of the devices
currently in use confirm to this shape. With a large device in a
large defect, significant residual leak was expected around
this device. This was seen in our patient also where though
there was a marked decrease in MR with the first device, sig-
nificant MR persisted. For more stability with a second device,
we chose a muscular VSD closure device. There have been
earlier case reports where more than one device have been
used for PVL.5 Most of these cases used additional coils or
smaller devices, however our patient had a very large PVL and
hence needed a large second device. To the best of our
knowledge these are the largest two devices for a single PVL.
Smaller sizes of this device easily slipped out across the first
device and a stable position was achieved only with an 18mm
device. Since the device sizes were large, they probably were
limited by the cage of the valve from interfering in the
movement of the ball. Very minimal MR remained post
procedure.4. Conclusion
This case demonstrates successful closure of a very large PVL
in a high-risk case. Very large PVL in itself need not be
considered an indication for surgery or be confined tomedical
therapy but it is important to ensureminimal residual MR post
procedure for the patient to have long-term benefit. Device
closure of PVLs should be considered in all patients with a
symptomatic PVL and is technically feasible even in large
leaks.Conflicts of interest
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